申请人:Shionogi & Co., Ltd.
公开号:EP2772480A1
公开(公告)日:2014-09-03
The present invention provides a novel compound having an antiviral action, in particular, an HIV replication inhibiting action, as well as a pharmaceutical composition, in particular, an anti-HIV agent.
wherein, a broken line means the presence or absence of a bond; R1 is substituted or unsubstituted alkyl etc., R2 is substituted or unsubstituted alkyloxy etc.; n is 1 or 2; R3 is a substituted or unsubstituted aromatic carbocyclic group; R4 is a hydrogen atom etc.; R5 is a substituted or unsubstituted aromatic carbocyclic group etc.; Y is a single bond etc.; R6 is substituted or unsubstituted alkyl; R7 is -Z-R71 etc.; Z is - NR72-CO- etc.; R71 is substituted or unsubstituted alkyl etc.; R72 is a hydrogen atom etc.
本发明提供了一种具有抗病毒作用,特别是抑制艾滋病毒复制作用的新型化合物,以及一种药物组合物,特别是一种抗艾滋病毒制剂。
其中,断线表示存在或不存在键;R1 是取代或未取代的烷基等、R2 是取代或未取代的烷氧基等;n 是 1 或 2;R3 是取代或未取代的芳香族碳环基团;R4 是氢原子等;R5 是取代或未取代的芳香族碳环基团等;Y 是单键等;R6 是取代或未取代的烷基;R7 是-Z-R71 等;Z 是-NR72-CO- 等;R71 是取代或未取代的烷基等;R72 是氢原子等。